𝔖 Bobbio Scriptorium

✦ LIBER ✦

Oxaliplatin As Part of Adjuvant Therapy for Colon Cancer: More Complicated Than Once Thought

✍ Scribed by Mayer, R. J.

Book ID: 115538204
Publisher: American Society of Clinical Oncology
Year: 2012
Tongue: English
Weight: 55 KB
Volume: 30
Category: Article
ISSN: 0732-183X
DOI: 10.1200/jco.2012.44.1949

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term neurotoxicity effects of oxali

Long-term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: Results from National Surgical Adjuvant Breast and Bowel Project trials C-07 and LTS-01

✍ Kelley M. Kidwell; Greg Yothers; Patricia A. Ganz; Stephanie R. Land; Clifford Y 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 820 KB

Adjuvant chemotherapy with oxaliplatin,

Adjuvant chemotherapy with oxaliplatin, in combination with fluorouracil plus leucovorin prolongs disease-free survival, but causes more adverse events in people with stage II or III colon cancer: Abstracted from: André T, Boni C, Mounedji-Boudiaf L, et al. Multicenter international study of oxaliplatin/5-fluorouracil/leucovorin in the adjuvant treatment of colon cancer (MOSAIC) investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343–51

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 213 KB

617 POSTER Initial safety findings from

617 POSTER Initial safety findings from XELOXA: a randomised phase III trial of capecitabine plus oxaliplatin vs. bolus 5-FU/LV as adjuvant therapy for patients (pts) with stage III colon cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 122 KB